Department of Clinical Pharmacology and Flinders Centre for Innovation in Cancer, Flinders University School of Medicine, Adelaide, Australia (P.K., T.M.P., M.J.S., J.O.M., A.R.); Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand (P.K.); Faculty of Pharmacy, University of Sydney, Sydney, Australia (A.J.M.); and University of Sheffield (Emeritus), Sheffield, United Kingdom (G.T.T.)

Department of Clinical Pharmacology and Flinders Centre for Innovation in Cancer, Flinders University School of Medicine, Adelaide, Australia (P.K., T.M.P., M.J.S., J.O.M., A.R.); Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand (P.K.); Faculty of Pharmacy, University of Sydney, Sydney, Australia (A.J.M.); and University of Sheffield (Emeritus), Sheffield, United Kingdom (G.T.T.)

Department of Clinical Pharmacology and Flinders Centre for Innovation in Cancer, Flinders University School of Medicine, Adelaide, Australia (P.K., T.M.P., M.J.S., J.O.M., A.R.); Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand (P.K.); Faculty of Pharmacy, University of Sydney, Sydney, Australia (A.J.M.); and University of Sheffield (Emeritus), Sheffield, United Kingdom (G.T.T.)

Department of Clinical Pharmacology and Flinders Centre for Innovation in Cancer, Flinders University School of Medicine, Adelaide, Australia (P.K., T.M.P., M.J.S., J.O.M., A.R.); Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand (P.K.); Faculty of Pharmacy, University of Sydney, Sydney, Australia (A.J.M.); and University of Sheffield (Emeritus), Sheffield, United Kingdom (G.T.T.)

Department of Clinical Pharmacology and Flinders Centre for Innovation in Cancer, Flinders University School of Medicine, Adelaide, Australia (P.K., T.M.P., M.J.S., J.O.M., A.R.); Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand (P.K.); Faculty of Pharmacy, University of Sydney, Sydney, Australia (A.J.M.); and University of Sheffield (Emeritus), Sheffield, United Kingdom (G.T.T.)

Department of Clinical Pharmacology and Flinders Centre for Innovation in Cancer, Flinders University School of Medicine, Adelaide, Australia (P.K., T.M.P., M.J.S., J.O.M., A.R.); Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand (P.K.); Faculty of Pharmacy, University of Sydney, Sydney, Australia (A.J.M.); and University of Sheffield (Emeritus), Sheffield, United Kingdom (G.T.T.)

Department of Clinical Pharmacology and Flinders Centre for Innovation in Cancer, Flinders University School of Medicine, Adelaide, Australia (P.K., T.M.P., M.J.S., J.O.M., A.R.); Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand (P.K.); Faculty of Pharmacy, University of Sydney, Sydney, Australia (A.J.M.); and University of Sheffield (Emeritus), Sheffield, United Kingdom (G.T.T.)